Sol-Gel is seeking to expand its pipeline of dermatological drug products by licensing-in clinically-proven drug candidates.
If you own a dermatological drug candidate at a clinical stage and you are interested in expediting its development, please use the form below to contact our VP of Research & Development.

Sol-Gel is also open for licensing-out its proprietary, innovative encapsulation technology for improving the efficacy and/or tolerability of dermatological drugs that are already in the market. 
If you are interested to achieve the same for the benefit of your patients and to gain further patent protection, please use the form below to contact our VP of Research & Development.